Literature DB >> 27435073

HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.

Catherine E Oldenburg1, Bao Le2, Trang Toan2, Dinh Duc Thien2, Hoang Thi Huyen2, Mackey R Friedman3, Ron Stall3, Donn Colby4,5.   

Abstract

Few studies have considered acceptability of HIV pre-exposure prophylaxis (PrEP) among transgender women in Southeast Asia. We assessed PrEP indications and readiness among a sample of HIV-uninfected transgender women in Ho Chi Minh City, Vietnam. Of 168 HIV-uninfected transgender women, 72.6 % met criteria for PrEP based on United States CDC guidelines. PrEP indication was inversely associated with PrEP interest (76.0 % interested among those for whom PrEP was indicated; 89.1 % among those for whom it was not; aOR 0.16, 95 % CI 0.04-0.67, P = 0.01). PrEP readiness, defined as having heard of, being interested in taking, and believing that PrEP is efficacious, was low (7.7 %). The results of this study indicate potential need for PrEP among transgender women in Ho Chi Minh City, but very low awareness of PrEP in the community. Future PrEP implementation programs should include counseling on HIV risk and eligibility for PrEP to ensure that PrEP is available to those who may benefit the most from it.

Entities:  

Keywords:  HIV; Pre-exposure prophylaxis; Transgender women; Vietnam

Mesh:

Substances:

Year:  2016        PMID: 27435073      PMCID: PMC5114147          DOI: 10.1007/s10461-016-1483-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  17 in total

1.  HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand.

Authors:  Suwat Chariyalertsak; Natthapol Kosachunhanan; Pongpun Saokhieo; Radchanok Songsupa; Antika Wongthanee; Chonlisa Chariyalertsak; Surasing Visarutratana; Chris Beyrer
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

4.  HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand.

Authors:  Thomas E Guadamuz; Wipas Wimonsate; Anchalee Varangrat; Praphan Phanuphak; Rapeepun Jommaroeng; Janet M McNicholl; Philip A Mock; Jordan W Tappero; Frits van Griensven
Journal:  AIDS Behav       Date:  2011-04

Review 5.  Sex work and HIV status among transgender women: systematic review and meta-analysis.

Authors:  Don Operario; Toho Soma; Kristen Underhill
Journal:  J Acquir Immune Defic Syndr       Date:  2008-05-01       Impact factor: 3.731

6.  Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.

Authors:  Lisa M Kuhns; Sari L Reisner; Matthew J Mimiaga; Travis Gayles; Michael Shelendich; Robert Garofalo
Journal:  AIDS Behav       Date:  2016-07

7.  Prevalence and risk factors associated with HIV infection among men having sex with men in Ho Chi Minh City, Vietnam.

Authors:  Tuan Anh Nguyen; Hien Tran Nguyen; Giang Truong Le; Roger Detels
Journal:  AIDS Behav       Date:  2007-06-27

Review 8.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.

Authors:  Stefan D Baral; Tonia Poteat; Susanne Strömdahl; Andrea L Wirtz; Thomas E Guadamuz; Chris Beyrer
Journal:  Lancet Infect Dis       Date:  2012-12-21       Impact factor: 25.071

9.  HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study.

Authors:  Donn Colby; Kriengkrai Srithanaviboonchai; Suphak Vanichseni; Sumet Ongwandee; Nittaya Phanuphak; Michael Martin; Kachit Choopanya; Suwat Chariyalertsak; Frits van Griensven
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

10.  Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.

Authors:  Albert Liu; Stephanie Cohen; Stephen Follansbee; Deborah Cohan; Shannon Weber; Darpun Sachdev; Susan Buchbinder
Journal:  PLoS Med       Date:  2014-03-04       Impact factor: 11.069

View more
  8 in total

1.  Pre and Post-exposure Prophylaxis Awareness and Acceptability Among Sex Workers in Jamaica: A Cross-Sectional Study.

Authors:  Carmen H Logie; Ying Wang; Patrick Lalor; Davina Williams; Kandasi Levermore
Journal:  AIDS Behav       Date:  2021-02

2.  Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.

Authors:  Venkatesan Chakrapani; Simran Shaikh; Visvanathan Arumugam; Umesh Chawla; Sonal Mehta
Journal:  Transgend Health       Date:  2021-04-16

3.  Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.

Authors:  Emilia M Jalil; Beatriz Grinsztejn; Luciane Velasque; Alessandra Ramos Makkeda; Paula M Luz; Ronaldo I Moreira; Luciana Kamel; Nilo M Fernandes; Ana Cristina G Ferreira; Brenda Hoagland; Sandra Wagner; Albert Liu; Willi McFarland; Susan Buchbinder; Valdilea G Veloso; Erin Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

4.  Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia.

Authors:  Jonathan M Galka; Melinda Wang; Iskandar Azwa; Britton Gibson; Sin How Lim; Roman Shrestha; Jeffrey A Wickersham
Journal:  Transgend Health       Date:  2020-12-11

5.  A qualitative assessment in acceptability and barriers to use pre-exposure prophylaxis (PrEP) among men who have sex with men: implications for service delivery in Vietnam.

Authors:  Long Hoang Nguyen; Huong Lan Thi Nguyen; Bach Xuan Tran; Mattias Larsson; Luis E C Rocha; Anna Thorson; Susanne Strömdahl
Journal:  BMC Infect Dis       Date:  2021-05-25       Impact factor: 3.090

6.  Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.

Authors:  Ashwin Belludi; Allison M McFall; Sunil Suhas Solomon; David D Celentano; Shruti H Mehta; A K Srikrishnan; M Suresh Kumar; Suniti Solomon; Gregory M Lucas
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

7.  Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.

Authors:  Venkatesan Chakrapani; Murali Shunmugam; Shruta Rawat; Dicky Baruah; Ruban Nelson; Peter A Newman
Journal:  AIDS Patient Care STDS       Date:  2020-01-17       Impact factor: 5.078

8.  Structural barriers to HIV prevention among men who have sex with men (MSM) in Vietnam: Diversity, stigma, and healthcare access.

Authors:  Morgan M Philbin; Jennifer S Hirsch; Patrick A Wilson; An Thanh Ly; Le Minh Giang; Richard G Parker
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.